Quantcast

Middle East and North Africa

Former FDA Reviewer joins Nuventra Pharma Sciences

DURHAM, N.C.–(BUSINESS WIRE)–Nuventra Pharma Sciences is pleased to announce the addition of Iftekhar Mahmood, Ph.D., to its growing team of

Posted in Europe, Middle East and North Africa, news | Tagged | Leave a comment

Neopharma, Elevar Therapeutics form JV to sell anticancer drug Rivoceranib

Abu Dhabi-based pharmaceutical manufacturer Neopharma and US-based Elevar Therapeutics formed a 50-50 joint venture in UAE, to organize selling Rivoceranib, a targeted anticancer drug and conduct clinical trials for other pipeline candidates.

Posted in Middle East and North Africa | Tagged , | Leave a comment

FDA reviews Foamix’s NDA for minocycline topical foam for Rosacea

The FDA has accepted for review Foamix’s New Drug Application (NDA) for FMX103 (minocycline topical foam 1.5%) topical foam, for the treatment of moderate-to-severe papulopustular rosacea in adults.

Posted in Middle East and North Africa, news, North America | Tagged , , | Leave a comment

Takeda sheds select OTC and non-core assets to Acino for over $200 M

Takeda said Tuesday it will sell certain OTC and non-core assets for over $200 million to ACino, to accelerate deleveraging as it said it will simplify portfolio in Takeda’s NEMEA region.

Posted in Middle East and North Africa, news | Tagged , | Leave a comment

MAGBIO Genomics makes automation friendly RNA purification chemistry for Mawi iSWAB-RNA-v2

HAYWARD, Calif.–(BUSINESS WIRE)–#Africa–Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces that MAGBIO

Posted in Middle East and North Africa, news | Tagged | Leave a comment

Teva to Present New Analyses of Fremanezumab Efficacy and Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Congress of the International Headache Society

Late breaking data examines 10-year cost effectiveness of fremanezumab, while one oral presentation and 29 posters highlight FOCUS Phase IIIb study data in adult patients with migraine and documented inadequate response to 2-4 classes of prior preventive treatments, along with patient survey results and post hoc efficacy results following the 1-year Phase III HALO long-term study

Posted in Middle East and North Africa, news | Tagged | Leave a comment

Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity – two common nerve agents

Nexien BioPharma was granted patent for “Use of Cannabinoids and Terpenes for Treatment of Organophosphate and Carbamate Toxicity” by the Israeli Patent Office.

Posted in Middle East and North Africa, news, North America | Tagged , , | Leave a comment

BiondVax Pharmaceuticals enrolls first patients to test flu vaccine candidate

@BiondVax Pharmaceuticals has enrolled first participants in the second cohort of the pivotal, clinical efficacy, Phase 3 trial of the M-001 universal #flu #vaccine candidate.

Posted in Middle East and North Africa, news | Tagged , | Leave a comment

Teva Presents Positive Results Showing Improvement in Disability and Quality of Life from the Phase IIIb FOCUS study of Fremanezumab in Adults with Migraine

These results include reduction in monthly average migraine days; reduction in migraine related symptoms; and improvements in depression status; work productivity and activity impairment.

Posted in Middle East and North Africa, news | Tagged , | Leave a comment

Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program

Takeda’s founding mission to serve patients, wherever they are, drives its increased commitments to disease prevention, capacity building, and access to healthcare in developing and emerging countries, in partnership with the global community.

Posted in Europe, Middle East and North Africa, news | Tagged | Leave a comment